Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Dutasteride Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Avodart
  • 1.3.3 Generic Avodart
• 1.4 Market Segment by Application
  • 1.4.1 Global Dutasteride Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Drug store
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Dutasteride Market Size
  • 2.1.1 Global Dutasteride Revenue 2014-2025
  • 2.1.2 Global Dutasteride Sales 2014-2025
• 2.2 Dutasteride Growth Rate by Regions
  • 2.2.1 Global Dutasteride Sales by Regions 2014-2019
  • 2.2.2 Global Dutasteride Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Dutasteride Sales by Manufacturers
  • 3.1.1 Dutasteride Sales by Manufacturers 2014-2019
  • 3.1.2 Dutasteride Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Dutasteride Revenue by Manufacturers (2014-2019)
  • 3.2.2 Dutasteride Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Dutasteride Market Concentration Ratio (CR5 and HHI)
• 3.3 Dutasteride Price by Manufacturers
• 3.4 Key Manufacturers Dutasteride Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Dutasteride Market
• 3.6 Key Manufacturers Dutasteride Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Avodart Sales and Revenue (2014-2019)
  • 4.1.2 Generic Avodart Sales and Revenue (2014-2019)
• 4.2 Global Dutasteride Sales Market Share by Type
• 4.3 Global Dutasteride Revenue Market Share by Type
• 4.4 Dutasteride Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Dutasteride Sales by Application

6 United States

• 6.1 United States Dutasteride Breakdown Data by Company
• 6.2 United States Dutasteride Breakdown Data by Type
• 6.3 United States Dutasteride Breakdown Data by Application

7 European Union

• 7.1 European Union Dutasteride Breakdown Data by Company
• 7.2 European Union Dutasteride Breakdown Data by Type
• 7.3 European Union Dutasteride Breakdown Data by Application

8 China

• 8.1 China Dutasteride Breakdown Data by Company
• 8.2 China Dutasteride Breakdown Data by Type
• 8.3 China Dutasteride Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Dutasteride Breakdown Data by Company
• 9.2 Rest of World Dutasteride Breakdown Data by Type
• 9.3 Rest of World Dutasteride Breakdown Data by Application
• 9.4 Rest of World Dutasteride Breakdown Data by Countries
  • 9.4.1 Rest of World Dutasteride Sales by Countries
  • 9.4.2 Rest of World Dutasteride Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GSK
  • 10.1.1 GSK Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Dutasteride
  • 10.1.4 Dutasteride Product Introduction
  • 10.1.5 GSK Recent Development
• 10.2 Bionpharma
  • 10.2.1 Bionpharma Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Dutasteride
  • 10.2.4 Dutasteride Product Introduction
  • 10.2.5 Bionpharma Recent Development
• 10.3 Rising Pharmaceuticals
  • 10.3.1 Rising Pharmaceuticals Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Dutasteride
  • 10.3.4 Dutasteride Product Introduction
  • 10.3.5 Rising Pharmaceuticals Recent Development
• 10.4 Teva
  • 10.4.1 Teva Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Dutasteride
  • 10.4.4 Dutasteride Product Introduction
  • 10.4.5 Teva Recent Development
• 10.5 Mylan
  • 10.5.1 Mylan Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Dutasteride
  • 10.5.4 Dutasteride Product Introduction
  • 10.5.5 Mylan Recent Development
• 10.6 Zydus
  • 10.6.1 Zydus Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Dutasteride
  • 10.6.4 Dutasteride Product Introduction
  • 10.6.5 Zydus Recent Development
• 10.7 Amneal Pharma
  • 10.7.1 Amneal Pharma Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Dutasteride
  • 10.7.4 Dutasteride Product Introduction
  • 10.7.5 Amneal Pharma Recent Development
• 10.8 Apotex
  • 10.8.1 Apotex Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Dutasteride
  • 10.8.4 Dutasteride Product Introduction
  • 10.8.5 Apotex Recent Development
• 10.9 Marksans Pharma
  • 10.9.1 Marksans Pharma Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Dutasteride
  • 10.9.4 Dutasteride Product Introduction
  • 10.9.5 Marksans Pharma Recent Development
• 10.10 Breckenridge Pharmaceutical
  • 10.10.1 Breckenridge Pharmaceutical Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Dutasteride
  • 10.10.4 Dutasteride Product Introduction
  • 10.10.5 Breckenridge Pharmaceutical Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Dutasteride Sales Channels
  • 11.2.2 Dutasteride Distributors
• 11.3 Dutasteride Customers

12 Market Forecast

• 12.1 Global Dutasteride Sales and Revenue Forecast 2019-2025
• 12.2 Global Dutasteride Sales Forecast by Type
• 12.3 Global Dutasteride Sales Forecast by Application
• 12.4 Dutasteride Forecast by Regions
  • 12.4.1 Global Dutasteride Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Dutasteride Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
In 2019, the market size of Dutasteride is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dutasteride.

This report studies the global market size of Dutasteride, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dutasteride sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical

Market Segment by Product Type
Avodart
Generic Avodart

Market Segment by Application
Hospital
Drug store

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Dutasteride status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dutasteride manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Dutasteride are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025